VirexpR announced that it has raised investment in an equity round of funding from new investor, Groupe Tera SA on April 28, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.88 EUR | -11.01% |
|
-11.01% | +2.11% |
Apr. 29 | Groupe Tera SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 18 | Oregon reconsiders drug decriminalization | RE |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.11% | 14.63M | |
+13.70% | 81.72B | |
+14.39% | 59.41B | |
+22.48% | 24.87B | |
+26.62% | 11.92B | |
+24.98% | 11.16B | |
+1.24% | 6.88B | |
+24.13% | 4.89B | |
+18.86% | 4.58B | |
-13.84% | 2.73B |
- Stock Market
- Equities
- ALGTR Stock
- News Groupe TERA
- VirexpR announced that it has received funding from Groupe Tera SA